Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 21.3% in 2024

Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 3.5 billion yuan in 2024, up 21.3% year-on-year.

Meanwhile, the company posted 41.1 billion yuan in revenue, down 0.8% year-on-year.

At the end of the reporting period, it had 117.5 billion yuan in total assets and 57.5 billion yuan in total liabilities, with a liability-to-asset ratio of 49%.